These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28675922)

  • 1. How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model.
    Troendle J; Leifer E; Zhang Z; Yang S; Tewes H
    Stat Med; 2017 Oct; 36(23):3654-3669. PubMed ID: 28675922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing causal effects in observational survival data using propensity score matching design.
    Lu B; Cai D; Tong X
    Stat Med; 2018 May; 37(11):1846-1858. PubMed ID: 29399833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general approach to evaluating the bias of 2-stage instrumental variable estimators.
    Wan F; Small D; Mitra N
    Stat Med; 2018 May; 37(12):1997-2015. PubMed ID: 29572890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
    Yu M; Xie D; Wang X; Weiner MG; Tannen RL
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation study.
    Galadima HI; McClish DK
    Pharm Stat; 2019 Oct; 18(5):568-582. PubMed ID: 31111682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored.
    Cécilia-Joseph E; Auvert B; Broët P; Moreau T
    Biom J; 2015 May; 57(3):371-83. PubMed ID: 25597640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
    Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis.
    Burne RM; Abrahamowicz M
    Stat Med; 2016 Nov; 35(25):4588-4606. PubMed ID: 27306611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.
    Yang S; Prentice RL
    Stat Med; 2015 May; 34(11):1801-17. PubMed ID: 25689356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer.
    Zahl PH; Mæhlen J
    PLoS One; 2015; 10(5):e0124076. PubMed ID: 25938446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable: an illustrative case study of cancer risk of patients on glucose-lowering therapies.
    Ng ES; Klungel OH; Groenwold RH; van Staa TP
    Pharm Stat; 2015; 14(5):382-94. PubMed ID: 26123413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.
    MacKenzie TA; Martinez-Camblor P; O'Malley AJ
    BMC Med Res Methodol; 2021 Mar; 21(1):56. PubMed ID: 33743583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Method for Partial Correction of Residual Confounding in Time-Series and Other Observational Studies.
    Flanders WD; Strickland MJ; Klein M
    Am J Epidemiol; 2017 May; 185(10):941-949. PubMed ID: 28430842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.